Jenburkt Pharmaceuticals Ltd. (JENBURPH)
Market Closed
5 Aug, 22:00
MSE MSE Primary ₹
1,111. 35
+11.3
+1.0272%
₹
4.45B Market Cap
20.75 P/E Ratio
72% Div Yield
1,371 Volume
0 Eps
₹ 1,100.05
Previous Close Want to track JENBURPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jenburkt Pharmaceuticals Ltd. (JENBURPH) Statistics
Valuation metrics
Market Cap 4.45B
Enterprise value 4.25B
Trailing P/E (ttm) 13.68
Forward P/E 28.99
PEG ratio 1.64
Price/Sales (ttm) 2.82
Price/Book (mrq) 2.41
Enterprise Value/Revenue 2.52
Enterprise Value/EBITDA 8.48
Overview
Shares outstanding 4.41M
Float 1.26M
Shares short -
% Held by insiders 0.64%
% Held by institutions -
Average volume (10 days) 1.38K
Average volume (90 days) 1.86K
Price summary
52-Week low 944
52-Week high 1,321
Beta 0.31
50-Day moving average 1,109.51
200-Day moving average 1,078.22
Dividends and splits
Forward annual dividend rate 72
Forward annual dividend yield 0.0712%
Trailing annual dividend rate 18
Trailing annual dividend yield 0.0167%
5-Year annual dividend yield 2.04%
Payout ratio 0.24
Dividend Date 17 Aug 2025
Ex-Dividend Date 11 Jul 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.21%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.19%
Income Statement
Revenue (ttm) 1.65B
Revenue per share (ttm) 382.29
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 1.32B
EBITDA 433.27M
Net income to common (ttm) 324.23M
Diluted EPS (ttm) 78.7
Quarterly earnings growth (yoy) -0.09%
Balance Sheet
Total cash (mrq) 96.48M
Total cash per share (mrq) 120.33
Total debt (mrq) 17.08M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.11%
Book value per share (mrq) 446.4
Cash Flow
Cash flow statement 252.79M
Levered free cash flow (LFCF) 320.61M
